• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Imidazole ribonucleosides and ribonucleotides 1-ribosyl-imidazolecarboxamides

Introduction to 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide (CAS No. 3676-69-5)

5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide, identified by its Chemical Abstracts Service (CAS) number 3676-69-5, is a structurally complex organic compound that has garnered significant attention in the field of medicinal chemistry and biochemistry. This compound belongs to the imidazole derivatives class, which is well-documented for its diverse pharmacological properties and biological activities. The presence of a ribofuranosyl moiety in its structure suggests potential applications in the development of nucleoside analogs, which are widely studied for their roles in inhibiting viral replication and cancer cell proliferation.

The chemical structure of 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide consists of an imidazole ring substituted with an amino group at the 5-position and a ribofuranosyl moiety linked to the 1-position of the imidazole ring. The ribofuranosyl unit is further modified with an isopropylidene acetal group at the 2 and 3 positions, enhancing its stability and solubility in various solvents. This structural feature makes it a promising candidate for further chemical modifications and derivatization, which could lead to novel bioactive compounds.

Recent advancements in synthetic chemistry have enabled the efficient preparation of 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide, facilitating its exploration in various biological assays. The compound has been investigated for its potential antiviral and anticancer properties. Studies have shown that imidazole derivatives can interact with enzymes and receptors involved in viral replication, making them effective against a range of pathogens. Additionally, the ribofuranosyl moiety suggests potential applications in modulating metabolic pathways that are dysregulated in cancer cells.

In vitro studies have demonstrated that 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide exhibits inhibitory activity against certain enzymes that are crucial for viral replication. For instance, it has been found to inhibit the activity of thymidylate synthase (TS), an enzyme essential for DNA synthesis in viruses. This inhibition could lead to the development of new antiviral agents that target specific viral enzymes without affecting host cellular processes. Furthermore, the compound's ability to interfere with DNA synthesis may also make it effective against rapidly dividing cancer cells.

The ribofuranosyl component of 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide is particularly noteworthy due to its similarity to natural nucleosides. This similarity allows the compound to potentially mimic nucleoside substrates in enzymatic reactions, thereby interfering with normal metabolic pathways. Such mechanisms have been exploited in the development of nucleoside analogs like acyclovir and azidothymidine (AZT), which are widely used in antiviral therapies. The structural features of 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide may enable it to exhibit similar effects with potentially improved efficacy or reduced toxicity.

Recent research has also explored the potential role of 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide in modulating immune responses. Imidazole derivatives have been shown to interact with immune cells and cytokines, influencing both innate and adaptive immune functions. The compound's ability to modulate these pathways could make it useful in treating immunodeficiency disorders or in enhancing vaccine efficacy. Additionally, its structural similarity to natural nucleotides may allow it to interfere with microbial metabolism, offering a new strategy for combating infections.

The synthesis of 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide involves multiple steps, including glycosylation reactions and protection-deprotection strategies to ensure regioselectivity and yield optimization. Advances in synthetic methodologies have enabled more efficient routes to this compound, reducing the need for hazardous reagents and improving overall sustainability. These improvements are crucial for scaling up production while maintaining high purity standards required for pharmaceutical applications.

The pharmacokinetic properties of 5-Amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)imidazole-4-carboxamide are also under investigation. Understanding how the compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for determining its therapeutic potential and optimizing drug delivery systems. Preliminary studies suggest that modifications to the ribofuranosyl moiety can significantly impact solubility and bioavailability, making it possible to enhance oral bioavailability or improve tissue penetration.

In conclusion,5-Amino-1-(2,3-O-isopropylidene-beta-D ri bofu ran os yl )imi daz ol -4 -car box am ide (CAS No. 3676 -69 -5 ) represents a promising candidate for further exploration in medicinal chemistry . Its unique structure , combining an im idaz ol ring with a ribo furanos yl moiety , offers multiple avenues for therapeutic intervention . Whether through antiviral , anticancer , or immunomodulatory mechanisms , this compound holds significant promise f or future research . As synthetic methods continue t o improve , so too will our ability t o harness its potential f or human health benefits .

• 7506-62-9(Glycine, N-[(5-amino-1-b-D-ribofuranosyl-1H-imidazol-4-yl)carbonyl]-)
• 64044-31-1(1H-Imidazole-4-carboxamide,5-amino-1-b-D-ribopyranosyl- (9CI))
• 3031-94-5(5-Aminoimidazole-4-carboxamide-1-b-D-Ribofuranosyl 5’-Monophosphate)
• 55781-70-9(1H-Imidazole-4-carboxamide,5-amino-1-a-D-arabinopyranosyl- (9CI))
• 2140-11-6(2',3'-O-Isopropylideneinosine)
• 37642-56-1(1H-Imidazole-4-carboxamide,5-amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-)
• 23274-21-7(5-Amino-1-(2’,3’,5’-tri-O-acetyl-b-D-ribofuranosyl)-imidazole-4-carboxamide)
• 142344-87-4(GP531)
• 55781-71-0(1H-Imidazole-4-carboxamide,5-amino-1-b-D-arabinopyranosyl- (9CI))
• 56220-55-4(1H-Imidazole-4-carboxamide,5-amino-1-(3-deoxy-b-D-erythro-pentofuranosyl)-)